- Home
- ALXO vs PSHG Comparison
ALXO vs PSHG Comparison
Compare ALXO & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- PSHG
- Stock Information
- Founded
- ALXO 2015
- PSHG 2010
- Country
- ALXO United States
- PSHG Greece
- Employees
- ALXO N/A
- PSHG N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- PSHG Marine Transportation
- Sector
- ALXO Health Care
- PSHG Consumer Discretionary
- Exchange
- ALXO Nasdaq
- PSHG Nasdaq
- Market Cap
- ALXO 24.0M
- PSHG 20.8M
- IPO Year
- ALXO 2020
- PSHG N/A
- Fundamental
- Price
- ALXO $0.41
- PSHG $1.75
- Analyst Decision
- ALXO Strong Buy
- PSHG Strong Buy
- Analyst Count
- ALXO 6
- PSHG 1
- Target Price
- ALXO $3.30
- PSHG $6.50
- AVG Volume (30 Days)
- ALXO 613.7K
- PSHG 183.7K
- Earning Date
- ALXO 08-07-2025
- PSHG 07-24-2025
- Dividend Yield
- ALXO N/A
- PSHG N/A
- EPS Growth
- ALXO N/A
- PSHG N/A
- EPS
- ALXO N/A
- PSHG 1.58
- Revenue
- ALXO N/A
- PSHG $86,407,000.00
- Revenue This Year
- ALXO N/A
- PSHG N/A
- Revenue Next Year
- ALXO N/A
- PSHG $23.25
- P/E Ratio
- ALXO N/A
- PSHG $1.13
- Revenue Growth
- ALXO N/A
- PSHG N/A
- 52 Week Low
- ALXO $0.40
- PSHG $1.31
- 52 Week High
- ALXO $8.78
- PSHG $2.34
- Technical
- Relative Strength Index (RSI)
- ALXO 40.22
- PSHG 50.12
- Support Level
- ALXO $0.45
- PSHG $1.75
- Resistance Level
- ALXO $0.53
- PSHG $1.90
- Average True Range (ATR)
- ALXO 0.05
- PSHG 0.15
- MACD
- ALXO -0.01
- PSHG -0.02
- Stochastic Oscillator
- ALXO 4.98
- PSHG 14.49
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates six Aframax tanker vessels.